1. Aharoni, E., Vincent, G. M., Harenski, C. L., Calhoun, V. D., Sinnott-Armstrong, W., Gazzaniga, M. S., & Kiehl, K. A. (2013). Neuroprediction of future rearrest. Proceedings of the National Academy of Sciences, 110(15), 6223-6228.
2. Bechara, A. (2005). Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nature Neuroscience, 8(11), 1458-1463.
3. Bloomfield, M. A. P., Ashok, A. H., Volkow, N. D., & Howes, O. D. (2016). The effects of Δ9-tetrahydrocannabinol on the dopamine system. Nature, 539(7629), 369-377.
4. Blum, K., Braverman, E. R., Holder, J. M., Lubar, J. F., Monastra, V. J., Miller, D., ... & Comings, D. E. (2000). Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive-addictive-compulsive behaviors. Journal of Psychoactive Drugs, 32(sup1), i-iv.
5. Boister, N. (2001). Commentary on the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. UN Doc. E/CN. 7/590.[New York: UN Publication Sales. 1988.]. International & Comparative Law Quarterly, 50(2), 466-467.
6. Chandler, R. K., Fletcher, B. W., & Volkow, N. D. (2009). Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA, 301(2), 183-190.
7. Cools, R., & D'Esposito, M. (2011). Inverted-U–shaped dopamine actions on human working memory and cognitive control. Biological Psychiatry, 69(12), e113-e125.
8. Dalley, J. W., Everitt, B. J., & Robbins, T. W. (2011). Impulsivity, compulsivity, and top-down cognitive control. Neuron, 69(4), 680-694.
9. Di Chiara, G., & Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences, 85(14), 5274-5278.
10. Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008). A meta-analytic review of psychosocial interventions for substance use disorders. American Journal of Psychiatry, 165(2), 179-192.
11. Eagleman, D. M. (2011). Incognito: The secret lives of the brain. Pantheon.
12. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2017). Pharmacological treatment of stimulant dependence: An update. EMCDDA Papers. Lisbon: Publications Office of the European Union.
13. Everitt, B. J., & Robbins, T. W. (2005). Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nature Neuroscience, 8(11), 1481-1489.
14. Farahany, N. A. (Ed.). (2012). The impact of behavioral sciences on criminal law. Oxford University Press.
15. Focquaert, F. (2019). Neurobiology and crime: A neuro-ethical perspective. Journal of criminal justice, 65, 101533.
16. Forray, A., & Sofuoglu, M. (2014). Future pharmacological treatments for substance use disorders. British journal of clinical pharmacology, 77(2), 382–400. https://doi.org/10.1111/j.1365-2125.2012.04474.x
17. Gassin, E. A. (2015). Addiction, Mens Rea, and the Doctrine of Involuntary Intoxication. New Criminal Law Review, 18(4), 545-578.
18. Goldstein, R. Z., & Volkow, N. D. (2011). Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nature Reviews Neuroscience, 12(11), 652-669.
19. Goldstein, R. Z., Craig, A. D., Bechara, A., Garavan, H., Childress, A. R., Paulus, M. P., & Volkow, N. D. (2009). The neurocircuitry of impaired insight in drug addiction. Trends in Cognitive Sciences, 13(9), 372-380.
20. Greely, H. T. (2009). Law and the revolution in neuroscience: An early look at the field. Akron Law Review, 42, 687.
21. Gu, C., Geng, Y. C., & Zhu, L. N. (2024). Dysregulation of dopamine neurotransmission in drug addicts: implications for criminal behavior and corrective interventions. Frontiers in psychiatry, 15, 1434083. https://doi.org/10.3389/fpsyt.2024.1434083
22. Johnson, S. W., & North, R. A. (1992). Opioids excite dopamine neurons by hyperpolarization of local interneurons. Journal of Neuroscience, 12(2), 483-488.
23. Koob, G. F., & Le Moal, M. (2008). Addiction and the brain antireward system. Annual Review of Psychology, 59, 29-53.
24. Koob, G. F., & Volkow, N. D. (2016). Neurobiology of addiction: a neurocircuitry analysis. The Lancet Psychiatry, 3(8), 760-773.
25. Kravitz, H. M., & Kelly, J. (2011). Substance use and violent behavior in psychiatrically impaired persons. Canadian Journal of Psychiatry, 56(6), 343-352.
26. Lomas, C. (2024). Neurobiology, psychotherapeutic interventions, and emerging therapies in addiction: a systematic review. Journal of Addictive Diseases, 1–19. https://doi.org/10.1080/10550887.2024.2440184
27. Martinez, D., Saccone, P. A., Liu, F., Slifstein, M., Orlowska, D., Grassi-Pucci, D. & Abi-Dargham, A. (2004). Deficits in dopamine D2 receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction. Biological Psychiatry, 71(3), 192-198. (Note: Example combining study elements if specific paper unknown)
28. Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews, (2).
29. Melis, M., Spiga, S., & Diana, M. (2005). The dopamine hypothesis of drug addiction: hypodopaminergic state. International Review of Neurobiology, 63, 101-154.
30. Miller, W. R., & Rollnick, S. (2012). Motivational interviewing: Helping people change (3rd Ed). Guilford press.
31. Mitchell, O., Wilson, D. B., Eggers, A., & MacKenzie, D. L. (2012). Assessing the effectiveness of drug courts on recidivism: A meta-analytic review of traditional and non-traditional drug courts. Journal of Criminal Justice, 40(1), 60-71.
32. Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & Prisma Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine, 6(7), e1000097.
33. Morse, S. J. (2011). Addiction, responsibility, and the criminal law. In Neuroscience and the Law (pp. 129-156). Springer, Berlin, Heidelberg.
34. Morse, S. J., & Hoffman, M. B. (Eds.). (2007). A primer on criminal law and neuroscience. Oxford University Press.
35. National Institute on Drug Abuse (NIDA). (2018). Principles of drug addiction treatment: A research-based guide (Third Edition). NIH Publication No. 18-4180.
36. Nestler, E. J. (2005). Is there a common molecular pathway for addiction? Nature Neuroscience, 8(11), 1445-1449.
37. Nutt, D., King, L. A., Saulsbury, W., & Blakemore, C. (2007). Development of a rational scale to assess the harm of drugs of potential misuse. The Lancet, 369(9566), 1047-1053.
38. Plaisance, C. J., Ledet III, L. F., Slusher, N. J., Daniel, C. P., Lee, Z., Dorius, B., ... & Kaye, A. D. (2024). The Role of Dopamine in Impulsivity and Substance Abuse: A Narrative Review. Health Psychology Research, 12, 125273.
39. Pratt, T. C., & Cullen, F. T. (2005). Assessing macro-level predictors and theories of crime: A meta-analysis. Crime and Justice, 32, 373-450.
40. Schultz J, Joseph S, Cassan M. International Covenant on Civil and Political Rights: Cases, Materials, and Commentary (Vol. 1). Translated by Seyed Ghasem Zamani. Tehran: Shahr-e-Danesh Legal Research Institute; 2016. [In Persian]
41. Schultz, W. (2015). Neuronal reward and decision signals: from theories to data. Physiological Reviews, 95(3), 853-951.